InvestorsHub Logo
Followers 65
Posts 3708
Boards Moderated 0
Alias Born 03/22/2020

Re: None

Sunday, 04/28/2024 11:40:54 PM

Sunday, April 28, 2024 11:40:54 PM

Post# of 198205
Just to keep up to date on the Dr. I feel we have lost out because of Harry and his buddy.

#AdnexusBiotechnologies has recently added a valuable asset to its therapeutics portfolio. #Sanctum Therapeutics' HIV capsid inhibitor has shown promising results in neutralizing HIV, making it a valuable addition to Adnexus' asset portfolio. By combining our expertise with that of the members of the Sanctum team, who have advanced knowledge in chemistry, pharmacology, in-silico methodology, and drug manufacturing, Adnexus will be able to develop valuable therapeutics independently and expand our #AI #drugdiscovery capabilities.